Jade Biosciences JBIO
NASDAQ JBIO
$19.91 +0.06 (+0.30%)
As of: Sep 4, 2026 · 3:59 PM EDT

Jade Biosciences (JBIO) Interest Coverage Ratio (2021 - 2024)

Jade Biosciences' (JBIO) quarterly Interest Coverage Ratio came in at 40.99 in Q1 2026, down 390.76% YoY from 14.1 in Q1 2025, and down 4283.38% on a QoQ basis from 0.94 in Q3 2025.

Analysis

Jade Biosciences (JBIO) Interest Coverage Ratio (2021 - 2024) Analysis & Trends

Jade Biosciences (JBIO) has 7 years of Interest Coverage Ratio data on file, last reported at 40.99 in Q1 2026.

  • Quarterly Interest Coverage Ratio fell 390.76% year-over-year to 40.99 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 126.04 (down 256.8% YoY) and the FY2025 annual result came in at 31.54, down 219.47% from the prior year.
  • Interest Coverage Ratio eased to 40.99 in Q1 2026, from 0.94 in the prior quarter.
  • In the past five years, Interest Coverage Ratio ranged from a high of 226.46 in Q4 2022 to a low of 1296.25 in Q3 2024.
  • A 5-year average of 89.78 and a median of 0.68 in 2023 frame the typical range for Interest Coverage Ratio.
  • Annual changes were most pronounced in 2022 — Interest Coverage Ratio soared 99.99% — and 2024, when it plunged 107571.01%.
  • Tracing JBIO's Interest Coverage Ratio over 5 years: stood at 226.46 in 2022, then tumbled by 181.88% to 185.43 in 2023, then sank by 599.06% to 1296.25 in 2024, then jumped by 99.93% to 0.94 in 2025, then plunged by 4283.38% to 40.99 in 2026.
  • The last three Interest Coverage Ratio figures came in at 40.99 (Q1 2026), 0.94 (Q3 2025), and 0.66 (Q2 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Interest Cover (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 117.59
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -493.00
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -
5 Revolution Medicines 44.33 Bn 44.33 Bn - -21.24
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 8.18
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 2.82
8 Royalty Pharma 28.45 Bn 27.61 Bn - 1.42
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn -0.08
10 Jade Biosciences 1.21 Bn 1.21 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2024 -4,360.83
Mar 31, 2024 -8,206.00
Jun 30, 2023 -20,336.00
Mar 31, 2023 -17,639.00
Jun 30, 2022 -2,035.83
Dec 31, 2021 8,268.00
Jun 30, 2021 -1,924.67
Mar 31, 2021 -2,780.00